S Rimondini

847 total citations
12 papers, 626 citations indexed

About

S Rimondini is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, S Rimondini has authored 12 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Surgery. Recurrent topics in S Rimondini's work include Sarcoma Diagnosis and Treatment (8 papers), Glioma Diagnosis and Treatment (2 papers) and Brain Metastases and Treatment (2 papers). S Rimondini is often cited by papers focused on Sarcoma Diagnosis and Treatment (8 papers), Glioma Diagnosis and Treatment (2 papers) and Brain Metastases and Treatment (2 papers). S Rimondini collaborates with scholars based in Italy. S Rimondini's co-authors include Alessandra Longhi, Stefano Ferrari, Cristiana Forni, Davide María Donati, Marco Manfrini, Franco Bertoni, Gaetano Bacci, Piero Picci, Patrizia Bacchini and G. Bacci and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and The Oncologist.

In The Last Decade

S Rimondini

12 papers receiving 607 citations

Peers

S Rimondini

PRM

ONCOL

RHEUM

CCM

SURGE

A. Brach del Prever Italy

Massimo Eraldo Abate Italy

Stefan Könemann Germany

A. Mancini Italy

J Pringle United Kingdom

Ermanno Emiliani Italy

Thomas Brodowicz Austria

Gamal El-Husseiny Saudi Arabia

Sumathi Vaiyapuri United Kingdom

Jennifer Worch Germany

A. Brach del Prever Italy

S Rimondini

573 ×1.1

PRM

232 ×1.1

ONCOL

264 ×1.5

RHEUM

148 ×1.0

CCM

170 ×1.4

SURGE

Citations per year, relative to S Rimondini S Rimondini (= 1×) peers A. Brach del Prever

Countries citing papers authored by S Rimondini

Since Specialization

Citations

This map shows the geographic impact of S Rimondini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Rimondini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Rimondini more than expected).

Fields of papers citing papers by S Rimondini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Rimondini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Rimondini. The network helps show where S Rimondini may publish in the future.

Co-authorship network of co-authors of S Rimondini

This figure shows the co-authorship network connecting the top 25 collaborators of S Rimondini. A scholar is included among the top collaborators of S Rimondini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Rimondini. S Rimondini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Pandolfi, Paolo, Natalina Collina, Giovanni Frezza, et al.. (2015). A Randomized Controlled Trial of Tong Len Meditation Practice in Cancer Patients: Evaluation of a Distant Psychological Healing Effect. EXPLORE. 12(1). 42–49. 9 indexed citations

Franceschi, Enrico, A. Tosoni, V. Blatt, et al.. (2007). 2518 POSTER Prolonged maintenance chemotherapy with Temozolomide (TMZ) after concomitant treatment in newly diagnosed GBM: safety profile. European Journal of Cancer Supplements. 5(4). 232–233. 1 indexed citations

Gori, Stefania, S Rimondini, Verena De Angelis, et al.. (2007). Central Nervous System Metastases in HER-2–Positive Metastatic Breast Cancer Patients Treated with Trastuzumab: Incidence, Survival, and Risk Factors. The Oncologist. 12(7). 766–773. 112 indexed citations

Franceschi, Enrico, Giovanni Cavallo, L. Scopece, et al.. (2004). Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma. British Journal of Cancer. 91(6). 1038–1044. 41 indexed citations

Bacci, G., Stefano Ferrari, A. Tienghi, et al.. (2001). A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity. European Journal of Surgical Oncology. 27(1). 98–104. 32 indexed citations

Bacci, Gaetano, Stefano Ferrari, Franco Bertoni, et al.. (2000). Prognostic Factors in Nonmetastatic Ewing’s Sarcoma of Bone Treated With Adjuvant Chemotherapy: Analysis of 359 Patients at the Istituto Ortopedico Rizzoli. Journal of Clinical Oncology. 18(1). 4–4. 226 indexed citations

Bacci, Gaetano, Stefano Ferrari, Franco Bertoni, et al.. (2000). Neoadjuvant Chemotherapy for Peripheral Malignant Neuroectodermal Tumor of Bone: Recent Experience at the Istituto Rizzoli. Journal of Clinical Oncology. 18(4). 885–885. 23 indexed citations

Bacci, G., A Briccoli, Stefano Ferrari, et al.. (2000). Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.. Oncology Reports. 7(2). 339–46. 47 indexed citations

Ferrari, Stefano, Mario Mercuri, Piero Picci, et al.. (1999). Nonmetastatic Osteosarcoma of the Extremity: Results of a Neoadjuvant Chemotherapy Protocol (IOR/OS-3) with High-dose Methotrexate, Intraarterial or Intravenous Cisplatin, Doxorubicin, and Salvage Chemotherapy Based on Histologic Tumor Response. Tumori Journal. 85(6). 458–464. 68 indexed citations

10.

Bacci, G., Stefano Ferrari, Alessandra Longhi, et al.. (1999). Prognostic significance of serum LDH in Ewing's sarcoma of bone.. Oncology Reports. 6(4). 807–11. 31 indexed citations

11.

Bacci, G., Michele Fiore, S Rimondini, & Nicola Baldini. (1999). Delayed diagnosis and tumor stage in Ewing's sarcoma.. Oncology Reports. 6(2). 465–6. 13 indexed citations

12.

Ferrari, S., M. Mercuri, P Rosito, et al.. (1998). Ifosfamide and Actinomycin-D, Added in the Induction Phase to Vincristine, Cyclophosphamide and Doxorubicin, Improve Histologic Response and Prognosis in Patients with Non Metastatic Ewing's Sarcoma of the Extremity. Journal of Chemotherapy. 10(6). 484–491. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact